Top

Langenbeck's Archives of Surgery

Published in:

01-11-2006 | New Surgical Horizons

Cigarette smoking: cancer risks, carcinogens, and mechanisms

Author: Stephen S. Hecht

Published in: Langenbeck's Archives of Surgery | Issue 6/2006

Abstract

Background

Cigarette smoking causes about 30% of all cancer mortality in developed countries. Although smoking is decreasing in developed countries, it is increasing in some developing countries.

Discussion

Cigarette smoke contains over 60 well established carcinogens. There are strong links between some of these carcinogens and various types of smoking-induced cancers. Mechanisms by which cigarette smoke carcinogens cause cancer are well established and are discussed here.

Conclusions

A great deal is known about cigarette smoke carcinogens and the mechanisms by which they cause cancer. It is hoped that this will provide new insights for the prevention and cure of tobacco-induced cancer.

Mackay J, Eriksen M (2002) The tobacco atlas. World Health Organization, Geneva, pp 24–27

International Agency for Research on Cancer (2004) Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans, vol 83. IARC, Lyon, FR, pp 53–119

International Agency for Research on Cancer (2004) Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans, vol 83. IARC, Lyon, FR, pp 1179–1187

Centers for Disease Control (2005) Cigarette smoking among adults—United States, 2004. MMWR 54:1121–1124

Wynder EL, Graham EA (1950) Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. A study of six hundred and eighty-four proved cases. JAMA 143:329–336

Doll R, Hill AB (1950) Smoking and carcinoma of the lung. A preliminary report. Br Med J ii:739–748CrossRef

U.S. Department of Health and Human Services (2004) The health consequences of smoking: a report of the surgeon general. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health, Rockville, MD

U.S.Department of Health and Human Services (2006) The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general. U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Washington, DC, p 709

Phillips DH (1983) Fifty years of benzo[a]pyrene. Nature 303:468–472PubMedCrossRef

10.

International Agency for Research on Cancer (1983) Polynuclear aromatic compounds, part 1, chemical, environmental, and experimental data. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol 32. IARC, Lyon, FR, pp 33–91

11.

Dipple A, Moschel RC, Bigger CAH (1984) Polynuclear aromatic hydrocarbons. In: Searle CE (ed) Chemical carcinogens, second edition, ACS monograph 182, vol 1. American Chemical Society, Washington, D.C., pp 41–163

12.

Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Cogliano V (2005) Carcinogenicity of polycyclic aromatic hydrocarbons. Lancet Oncol 6:931–932PubMedCrossRef

13.

Preussmann R,Stewart BW (1984) N-Nitroso carcinogens. In: Searle CE (ed) Chemical carcinogens, second edition, ACS monograph 182, vol 2. American Chemical Society, Washington, DC, pp 643–828

14.

Hecht SS, Hoffmann D (1988) Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 9:875–884PubMed

15.

Hecht SS (1998) Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11:559–603PubMedCrossRef

16.

International Agency for Research on Cancer (2006) Smokeless tobacco and tobacco-specific nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 89. IARC, Lyon, FR (in press)

17.

Luch A (2005) Nature and nurture—lessons from chemical carcinogenesis. Nat Rev Cancer 5:113–125PubMedCrossRef

18.

Sugimura T (1995) History, present and future, of heterocyclic amines, cooked food mutagens. Princess Takamatsu Symp 23:214–231PubMed

19.

International Agency for Research on Cancer (1995) Wood dust and formaldehyde. IARC monographs on the evaluation of carcinogenic risks to humans, vol 62. IARC, Lyon, FR, pp 217–362

20.

International Agency for Research on Cancer (1999) Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide (Part Two). IARC monographs on the evaluation of carcinogenic risks to humans, vol 71. IARC, Lyon, FR, pp 319–451

21.

International Agency for Research on Cancer (1993) Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol 56. IARC, Lyon, FR, pp 115–134

22.

International Agency for Research on Cancer (1999) Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide (part one). IARC monographs on the evaluation of carcinogenic risks to humans, vol 71. IARC, Lyon, FR, pp 109–225

23.

International Agency for Research on Cancer (1982) Some industrial chemicals and dyestuffs. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol 29. IARC, Lyon, FR, pp 93–148

24.

International Agency for Research on Cancer (1979) Some monomers, plastics and synthetic elastomers, and acrolein. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol 19. IARC, Lyon, FR, pp 377–438

25.

International Agency for Research on Cancer (1994) Some industrial chemicals. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol 60. IARC, Lyon, FR, pp 73–159

26.

Hecht SS (1999) Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91:1194–1210PubMedCrossRef

27.

Carmella SG, Chen M, Villalta PW, Gurney JG, Hatsukami DK, Hecht SS (2002) Ethylation and methylation of hemoglobin in smokers and non-smokers. Carcinogenesis 23:1903–1910PubMedCrossRef

28.

Singh R, Kaur B, Farmer PB (2005) Detection of DNA damage derived from a direct acting ethylating agent present in cigarette smoke by use of liquid chromatography-tandem mass spectrometry. Chem Res Toxicol 18:249–256PubMedCrossRef

29.

Hoffmann D, Schmeltz I, Hecht SS, Wynder EL (1978) Tobacco carcinogenesis. In: Gelboin H, Ts'o POP (eds) Polycyclic hydrocarbons and cancer. Academic, New York, pp 85–117

30.

Deutsch-Wenzel R, Brune H, Grimmer G (1983) Experimental studies in rat lungs on the carcinogenicity and dose–response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons. J Natl Cancer Inst 71:539–544PubMed

31.

Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21:7435–7451PubMedCrossRef

32.

Boysen G, Hecht SS (2003) Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods. Mutat Res 543:17–30PubMedCrossRef

33.

Phillips DH (2002) Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 23:1979–2004PubMedCrossRef

34.

Liu Z, Muehlbauer KR, Schmeiser HH, Hergenhahn M, Belharazem D, Hollstein MC (2005) p53 mutations in benzo(a)pyrene-exposed human p53 knock-in murine fibroblasts correlate with p53 mutations in human lung tumors. Cancer Res 65:2583–2587PubMedCrossRef

35.

Belinsky SA, Foley JF, White CM, Anderson MW, Maronpot RR (1990) Dose–response relationship between O ⁶-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 50:3772–3780PubMed

36.

Hecht SS (2002) Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23:907–922PubMedCrossRef

37.

Shapiro JA, Jacobs EJ, Thun MJ (2000) Cigar smoking in men and risk of death from tobacco-related cancers. J Natl Cancer Inst 92:333–337PubMedCrossRef

38.

Boffetta P, Pershagen G, Jockel KH, Forastiere F, Gaborieau V, Heinrich J, Jahn I, Kreuzer M, Merletti F, Nyberg F, Rosch F, Simonato L (1999) Cigar and pipe smoking and lung cancer risk: a multicenter study from Europe. J Natl Cancer Inst 91:697–701PubMedCrossRef

39.

Travis WD, Travis LB, Devesa SS (1995) Lung cancer. Cancer 75:191–202PubMedCrossRef

40.

Hoffmann D, Hoffmann I, El Bayoumy K (2001) The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol 14:767–790PubMedCrossRef

41.

International Agency for Research on Cancer (1986) Tobacco smoking. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol 38. IARC, Lyon, FR, pp 37–385

42.

Hoffmann D, Hecht SS (1990) Advances in tobacco carcinogenesis. In: Cooper CS, Grover PL (eds) Handbook of experimental pharmacology. Springer, Berlin Heidelberg New York, pp 63–102

43.

Lijinsky W (1992) Chemistry and biology Of N-nitroso compounds. Cambridge University Press, Cambridge, England

44.

Hecht SS, Hoffmann D (1989) The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv 8:273–294PubMed

45.

International Agency for Research on Cancer (1995) Dry cleaning, some chlorinated solvents and other industrial chemicals. IARC monographs on the evaluation of carcinogenic risks to humans, vol 63. IARC, Lyon, France, pp 393–407

46.

Prokopczyk B, Leder G, Trushin N, Cunningham AJ, Akerkar S, Pittman B, Ramadani M, Straeter J, Beger HG, Henne-Bruns D, El Bayoumy K (2005) 4-Hydroxy-1-(3-pyridyl)-1-butanone, an indicator for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA damage, is not detected in human pancreatic tissue. Cancer Epidemiol Biomarkers Prev 14:540–541PubMedCrossRef

47.

Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS (1988) Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 48:6912–6917PubMed

48.

Prokopczyk B, Hoffmann D, Bologna M, Cunningham AJ, Trushin N, Akerkar S, Boyiri T, Amin S, Desai D, Colosimo S, Pittman B, Leder G, Ramadani M, Henne-Bruns D, Beger HG, El Bayoumy K (2002) Identification of tobacco-derived compounds in human pancreatic juice. Chem Res Toxicol 15:677–685PubMedCrossRef

49.

Prokopczyk B, Trushin N, Leszczynska J, Waggoner SE, El Bayoumy K (2001) Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanone, via alpha-hydroxylation and carbonyl reduction pathways. Carcinogenesis 22:107–114PubMedCrossRef

50.

Melikian AA, Sun P, Prokopczyk B, El Bayoumy K, Hoffmann D, Wang X, Waggoner S (1999) Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer Lett 146:127–134PubMedCrossRef

51.

International Agency for Research on Cancer (1995) Human papillomaviruses. IARC monographs on the evaluation of carcinogenic risks to humans, vol 64. IARC, Lyon, FR, pp 35–378

52.

International Agency for Research on Cancer (1973) Some aromatic amines, hydrazine and related substances, N-nitroso compounds and miscellaneous alkylating agents. IARC monographs on the carcinogenic risk of chemicals to man, vol 4. IARC, Lyon, FR, pp 127–136

53.

Skipper PL, Tannenbaum SR (1990) Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11:507–518PubMed

54.

Skipper PL, Peng X, SooHoo CK, Tannenbaum SR (1994) Protein adducts as biomarkers of human carcinogen exposure. Drug Metab Rev 26:111–124PubMed

55.

Landi MT, Zocchetti C, Bernucci I, Kadlubar FF, Tannenbaum S, Skipper P, Bartsch H, Malaveille C, Shields P, Caporaso NE, Vineis P (1996) Cytochrome P450 1A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels. Cancer Epidemiol Biomark Prev 5:693–698

56.

Probst-Hensch NM, Bell DA, Watson MA, Skipper PL, Tannenbaum SR, Chan KK, Ross RK, Yu MC (2000) N-Acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl–hemoglobin adduct levels. Cancer Epidemiol Biomark Prev 9:619–623

57.

Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC (2001) Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 93:538–545PubMedCrossRef

58.

Pryor WA, Stone K, Zang LY, Bermudez E (1998) Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage. Chem Res Toxicol 11:441–448PubMedCrossRef

59.

Guengerich FP (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14:611–650PubMed

60.

Jalas J, Hecht SS, Murphy SE (2005) Cytochrome P450 2A enzymes as catalysts of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific carcinogen. Chem Res Toxicol 18:95–110PubMedCrossRef

61.

Nebert DW, Dalton TP, Okey AB, Gonzalez FJ (2004) Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279:23847–23850PubMedCrossRef

62.

Armstrong RN (1997) Glutathione-S-transferases. In: Guengerich FP (ed) Comprehensive toxicology: biotransformation, vol 3. Elsevier Science, New York, pp 307–327

63.

Burchell B, McGurk K, Brierley CH, Clarke DJ (1997) UDP-glucuronosyltransferases. In: Guengerich FP (ed) Comprehensive toxicology: biotransformation, vol 3. Elsevier Science, New York, pp 401–436

64.

Vineis P, Veglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Ingelman-Sundberg M, Kihara M, Kiyohara C, Kremers P, Le Marchand L, Ohshima S, Pastorelli R, Rannug A, Romkes M, Schoket B, Shields P, Strange RC, Stucker I, Sugimura H, Garte S, Gaspari L, Taioli E (2003) CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 104:650–657PubMedCrossRef

65.

Liu G, Zhou W, Christiani DC (2005) Molecular epidemiology of non-small cell lung cancer. Semin Respir Crit Care Med 26:265–272PubMedCrossRef

66.

Ahrendt SA, Decker PA, Alawi EA, Zhu Yr YR, Sanchez-Cespedes M, Yang SC, Haasler GB, Kajdacsy-Balla A, Demeure MJ, Sidransky D (2001) Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer 92:1525–1530PubMedCrossRef

67.

Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA, Jacks T (2001) Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410:1111–1116PubMedCrossRef

68.

Lubet RA, Zhang Z, Wiseman RW, You M (2000) Use of p53 transgenic mice in the development of cancer models for multiple purposes. Exp Lung Res 26:581–593PubMedCrossRef

69.

Sekido Y, Fong KW, Minna JD (1998) Progress in understanding the molecular pathogenesis of human lung cancer. Biochim Biophys Acta 1378:F21–F59PubMed

70.

Bode AM, Dong Z (2005) Signal transduction pathways in cancer development and as targets for cancer prevention. Prog Nucleic Acid Res Mol Biol 79:237–297PubMed

71.

Hecht SS (2003) Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nature Rev Cancer 3:733–744CrossRef

72.

Schuller HM (2002) Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer 2:455–463PubMedCrossRef

73.

West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, Harris C, Belinsky S, Dennis PA (2003) Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 111:81–90PubMedCrossRef

74.

Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, Tsao PS, Johnson FL, Cooke JP (2001) Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 7:833–839PubMedCrossRef

75.

Moraitis D, Du B, De Lorenzo MS, Boyle JO, Weksler BB, Cohen EG, Carew JF, Altorki NK, Kopelovich L, Subbaramaiah K, Dannenberg AJ (2005) Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands. Cancer Res 65:664–670PubMed

76.

Belinsky SA (2005) Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer. Carcinogenesis 26:1481–1487PubMedCrossRef

77.

World Health Organization (1997) Tobacco or health: a global status report. WHO, Geneva, pp 10–48

78.

Blot WJ, Fraumeni JF Jr (1996) Cancers of the lung and pleura. In: Schottenfeld D, Fraumeni J (eds) Cancer epidemiology and prevention. Oxford University Press, New York, pp 637–665

79.

American Cancer Society (2001) Cancer facts and figures 2001. American Cancer Society, Atlanta, GA, pp 29–32

Title: Cigarette smoking: cancer risks, carcinogens, and mechanisms
Author: Stephen S. Hecht
Publication date: 01-11-2006
Publisher: Springer-Verlag
Published in: Langenbeck's Archives of Surgery / Issue 6/2006
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-006-0111-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cigarette smoking: cancer risks, carcinogens, and mechanisms

Abstract

Background

Discussion

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Discussion

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2006

The use of LigaSure in patients with hyperthyroidism

Implantation of parathyroid carcinoma along fine needle aspiration track

The advantage of near-total thyroidectomy to avoid postoperative hypoparathyroidism in benign multinodular goiter

Genetic changes in advanced gastrointestinal stromal tumor (GIST) patients during imatinib mesylate treatment

Clinical outcome of different modes of resection in papillary thyroid carcinomas with laryngotracheal invasion

Supervised surgical trainees perform thyroid surgery for Graves’ disease safely